Murakawa, Yuji
Ikeda, Takanori
Ogawa, Satoshi
Kitazono, Takanari
Nakagawara, Jyoji
Minematsu, Kazuo
Miyamoto, Susumu
Hayashi, Yasuhiro
Kidani, Yoko
Okayama, Yutaka
Sunaya, Toshiyuki
Sato, Shoichiro
Yamanaka, Satoshi
Funding for this research was provided by:
Bayer Yakuhin, Ltd.
Article History
Received: 18 November 2019
Accepted: 13 March 2020
First Online: 6 April 2020
Compliance with ethical standards
:
: YM, TI, SO, TK, JN, KM, and SM were advisory board members for Bayer Yakuhin, Ltd. YM received research grants from Bayer Yakuhin, Ltd., Boehringer Ingelheim, and Daiichi Sankyo, and honoraria from Bayer Yakuhin, Ltd., Boehringer Ingelheim, Bristol-Myers Squibb, and Daiichi Sankyo. TI received research grants from Bayer Yakuhin, Ltd., Bristol-Myers Squibb, Daiichi Sankyo, Medtronic Japan, and St. Jude Medical, and honoraria from Bayer Yakuhin, Ltd., Bristol-Myers Squibb, Daiichi Sankyo, Ono, and Pfizer; TI was an advisory board member for Bristol-Myers Squibb. TK received a research grant from Bayer Yakuhin, Ltd. JN received a research grant from Nihon Medi-Physics. KM received honoraria from Astellas, AstraZeneca, Bayer Yakuhin, Ltd., BMS, Boehringer Ingelheim, Daiichi Sankyo, Japan Stryker, Kowa, Mitsubishi-Tanabe, Nihon Medi-Physics, Nippon Chemiphar, Otsuka, Pfizer, Sawai, and Sumitomo Dainippon; KM was an advisory board member for CSL Behring and Medico’s Hirata. SM received research grants from Astellas, Brainlab, Bristol-Myers Squibb, Carl Zeiss Meditec, Chugai, CSL Behring, Daiichi Sankyo, Eisai, Medtronic, Meiji, Mitsubishi-Tanabe, MSD, Mizuho, Nihon Medi-Physics, Otsuka, Pfizer, Philips Electronics Japan, Sanofi, Siemens Healthcare, and Takeda. YH, YK, YO, TS, SS, and SY are employees of Bayer Yakuhin, Ltd.